PURPOSE: We examined preoperative and postoperative patient related factors associated with continence status up to 7 years after surgery for stress urinary incontinence. MATERIALS AND METHODS: Women randomized to Burch colposuspension or fascial sling surgery and assessed for the primary outcome of urinary continence 2 years after surgery were eligible to enroll in a prospective observational study. Survival analysis was used to investigate baseline and postoperative factors in the subsequent risk of stress urinary incontinence, defined as self-report of stress urinary incontinence symptoms, incontinence episodes on a 3-day diary or surgical re-treatment. RESULTS: Of the women who participated in the randomized trial 74% (482 of 655) were enrolled in the followup study. Urinary continence rates decreased during a period of 2 to 7 years postoperatively from 42% to 13% in the Burch group and from 52% to 27% in the sling group, respectively. Among the baseline factors included in the first multivariable model age (p = 0.03), prior stress urinary incontinence surgery (p = 0.02), menopausal status (0.005), urge index (0.006), assigned surgery (p = 0.01) and recruiting site (p = 0.02) were independently associated with increased risk of incontinence. In the final multivariable model including baseline and postoperative factors, Burch surgery (p = 0.01), baseline variables of prior urinary incontinence surgery (p = 0.04), menopausal status (p = 0.03) and postoperative urge index (p <0.001) were each significantly associated with a greater risk of recurrent urinary incontinence. CONCLUSIONS:Preoperative and postoperative urgency incontinence symptoms, Burch urethropexy, prior stress urinary incontinence surgery and menopausal status were negatively associated with long-term continence rates. More effective treatment of urgency urinary incontinence in patients who undergo stress urinary incontinence surgery may improve long-term overall continence status.
RCT Entities:
PURPOSE: We examined preoperative and postoperative patient related factors associated with continence status up to 7 years after surgery for stress urinary incontinence. MATERIALS AND METHODS:Women randomized to Burch colposuspension or fascial sling surgery and assessed for the primary outcome of urinary continence 2 years after surgery were eligible to enroll in a prospective observational study. Survival analysis was used to investigate baseline and postoperative factors in the subsequent risk of stress urinary incontinence, defined as self-report of stress urinary incontinence symptoms, incontinence episodes on a 3-day diary or surgical re-treatment. RESULTS: Of the women who participated in the randomized trial 74% (482 of 655) were enrolled in the followup study. Urinary continence rates decreased during a period of 2 to 7 years postoperatively from 42% to 13% in the Burch group and from 52% to 27% in the sling group, respectively. Among the baseline factors included in the first multivariable model age (p = 0.03), prior stress urinary incontinence surgery (p = 0.02), menopausal status (0.005), urge index (0.006), assigned surgery (p = 0.01) and recruiting site (p = 0.02) were independently associated with increased risk of incontinence. In the final multivariable model including baseline and postoperative factors, Burch surgery (p = 0.01), baseline variables of prior urinary incontinence surgery (p = 0.04), menopausal status (p = 0.03) and postoperative urge index (p <0.001) were each significantly associated with a greater risk of recurrent urinary incontinence. CONCLUSIONS: Preoperative and postoperative urgency incontinence symptoms, Burch urethropexy, prior stress urinary incontinence surgery and menopausal status were negatively associated with long-term continence rates. More effective treatment of urgency urinary incontinence in patients who undergo stress urinary incontinence surgery may improve long-term overall continence status.
Authors: Kathryn L Burgio; Linda Brubaker; Holly E Richter; Clifford Y Wai; Heather J Litman; Diane Borello France; Shawn A Menefee; Larry T Sirls; Stephen R Kraus; Harry W Johnson; Sharon L Tennstedt Journal: Neurourol Urodyn Date: 2010-11 Impact factor: 2.696
Authors: L Brubaker; H E Richter; P A Norton; M Albo; H M Zyczynski; T C Chai; P Zimmern; S Kraus; L Sirls; J W Kusek; A Stoddard; S Tennstedt; E Ann Gormley Journal: J Urol Date: 2012-02-15 Impact factor: 7.450
Authors: Holly E Richter; Heather J Litman; Emily S Lukacz; Larry T Sirls; Leslie Rickey; Peggy Norton; Gary E Lemack; Stephen Kraus; Pamela Moalli; Mary Pat Fitzgerald; Kimberly J Dandreo; Liyuan Huang; John W Kusek Journal: Obstet Gynecol Date: 2011-04 Impact factor: 7.661
Authors: Linda Brubaker; Pamela Moalli; Holly E Richter; Michael Albo; Larry Sirls; Toby Chai; Stephen R Kraus; Peggy Norton; Debuene Chang; Sharon L Tennstedt Journal: Clin Trials Date: 2009-07-22 Impact factor: 2.486
Authors: Linda Brubaker; Anne Stoddard; Holly Richter; Philippe Zimmern; Pamela Moalli; Stephen R Kraus; Peggy Norton; Emily Lukacz; Larry Sirls; Harry Johnson Journal: Neurourol Urodyn Date: 2009 Impact factor: 2.696
Authors: Mauricio Plata; Daniela Robledo; Alejandra Bravo-Balado; Juan Carlos Castaño; Catalina Osorio; Milton Salazar; Juan Guillermo Velásquez; Carlos Gustavo Trujillo; Juan Ignacio Caicedo; Juan Guillermo Cataño Journal: Int Urogynecol J Date: 2018-03-03 Impact factor: 2.894
Authors: Toby C Chai; Holly E Richter; Pamela Moalli; Susan Keay; Joseph Biggio; Wenjun Zong; Teresa Curto; Hae-Young Kim; Anne M Stoddard; John W Kusek Journal: J Urol Date: 2013-10-16 Impact factor: 7.450